Apr 29, 2022
Apr 22, 2022
The iMATCH pilot: immunotherapy comes of age with a master protocol
Apr 8, 2022
Reversing resistance to PD-1 inhibitors with combination immunotherapy in patients with advanced melanoma
Mar 31, 2022
The spring 2022 newsletter for Lung-MAP participating sites is now available.
Mar 4, 2022
Feb 15, 2022
Survival data from the first prospective, randomized biomarker validation trial in muscle-invasive bladder cancer presented at GU ASCO
Feb 14, 2022
Higher toxicity risk for women was known for chemotherapy, now also identified for immunotherapy and targeted therapy